|
|
Post by joeypotsandpans on Feb 26, 2020 22:12:53 GMT -5
Joeypotsnpans: like your posts, but the argument that big pharma is blunting Afrezza is just not true. After 4 years we are not a pimple on their ass and haven’t produced enough volume for them to ever mentioned Mannkind. If they ever got scared of our science and product they would just buy us. The big pharma blunting effect is another farce. Trust me...Afrezza is not in their mouth when they are talking to prescribers. You're missing the point, they don't have to mention nor would they want to heed any attention directly to Afrezza....they just have to keep it off tier 2 formulary.... and the rest takes care of itself. They know the game because they are in it. SNY realized it was going to be a huge battle when they understood the insurance hurdle combined with the label. This isn't rocket science (no pun intended regarding speed). Make it near impossible for the patient to obtain and just play the system as it allows to be played. If Afrezza was tier 2, this board would have been gone a long long time ago with a lot of happy campers (Liane included) enjoying enriched lives monetarily and a lot of T1 and T2 patients enriched with improved health and lives in general. They know the science and thus why they have stealthily and shrewdly kept this incredible proxy for natural insulin out of patients hands. I guess NVO was quick to get FIASP on the market because they didn't feel threatened. The last thing they would want to do is mention Afrezza when talking to prescribers.....you're not seeing the bigger picture, perhaps you were born for better things than sales.  |
|
|
|
Post by joeypotsandpans on Feb 26, 2020 21:09:25 GMT -5
Oh man...never seen that posted before. Thanks for sharing. You're welcome, the fallout is not because of dosing etc. the fallout is strictly because of LLY and NVO blocking the best new kid off the shelf by substantially undercutting the price which allows United Healthcare and others the ability to deny coverage. It has been ongoing for 3 years and the smarter inside money knew that was going to be a tough mountain to move. I feel for the sales reps as they were fighting an almost impossible battle from day 1. The task at hand remains monumental, as I have mentioned before it takes a long time to take down a wall brick by brick, however, I am optimistic that it will happen. Best of luck to you -J |
|
|
|
Post by joeypotsandpans on Feb 26, 2020 20:57:16 GMT -5
sayhey24 is a type 2 and takes Afrezza. I hear he loves it, btw. There's more T2Ds on twitter I follow that use Afrezza and they also love it. So...apparently it works. but I know at least 5 Type 1's on Afrezza and LOVE IT. I know 2 Pediatric Endos who can't wait to put their patients on it. No one expected Afrezza to be an EARLY SUCCESS when you're going up against the BIG 3 Insulin Makers. I'll tell you one thing....Sanofi (the old CEO) knew the potential of Afrezza. We all know it was going to be a slow climb. Sales are climbing and MNKD is hiring more salespeople. AFREZZA WORKS and people love it. After MNKD gets Pediatric approval and hopefully an improved label.....They will sign a new marketing partner to handle the Type 2 Market. It's not going to happen over night but as long as sales are climbing LIFE IS CAN BE GOOD GREAT The following (below) is posted on the wall next to the patient chairs in the room that I had my office visit today at my endo. This T2 is extremely grateful for both my endo and the original SNY sales rep whose territory he came under. Dr Nguyen at Las Vegas Endocrinology has been prescribing Afrezza now since it's introduction into his practice right after it launched. He is a total advocate of the superior benefits and attributes that come with using Afrezza. I thank a greater power that everyone does not think the same as the OP of this thread. PG I am not sure what happened to you during your time with the company and I will not speculate as to whether you are disgruntled etc. but I can tell you wholeheartedly and without a doubt that Afrezza absolutely has a place with treating the disease in an advantageous fashion in T2 patients as it has been a godsend to me personally. Btw, I pay $100/quarter I have stated my opinion in the past so will not go down that path again regarding the slings and arrows that have unfortunately confronted Al's vision and mission. He absolutely underestimated forces that are nefarious beyond one's wildest dreams all for the almighty dollar. As much of a philanthropist as he was with the vision of helping those afflicted with this disease, among others that he worked on, his mindset was incapable of comprehending just how dark evil and greed could be. In some ways I think he is better off not having had to see it to this point as I can't imagine the frustration he personally would have felt. Having said that, I couldn't help but think as I looked on the wall of my endo's office and saw this that he would have taken some solace and smiled as he sees it from a better place.  |
|
|
|
Post by joeypotsandpans on Feb 22, 2020 13:19:18 GMT -5
Well this certainly is reassuring as I stealthily read these, smh, and chuckle |
|
|
|
Post by joeypotsandpans on Feb 20, 2020 20:30:41 GMT -5
MNKD share price has made a potential inverted head and shoulders over the past, 20 trading days a 16 cent measure, with a break out being, break and hold of $1.54. If you think there is any reason for buyers to come in, this is a good place to add to a position. $1.43 has to hold for the pattern to play out. .16 + $1.54 = $1.70 target if this price pattern plays out on this time frame. (a pennies business)  I see a retest of 1.75-1.80 and then the return to the 2.25 area....the first run-up hit extreme overbought conditions (see RSI beneath chart), that has been worked down to neutral strength 50 area again since this consolidation at the 1.50 area has held very well...looks like it's getting ready to resume the uptrend...we shall see ....will be seeing my endo next Wed. so script will be going to OPTUM...we'll see how much UHC has softened regarding coverage. |
|
|
|
Post by joeypotsandpans on Feb 16, 2020 15:22:48 GMT -5
I understand the sentiment, but never play chicken with the financial markets. The market is long overdue for a correction and while it is nice to have a high value deal signed, there are no guarantees that a deal can get done on good terms before the market goes soft. I have seen too many small biotechs play the waiting game and then found themselves trying to raise money in a declining or crashing market environment. None of those stories ended well hence the old adage "raise money when you can, not when you need it." Thanks matt. This is why I was not as upset as some people with the Christmas dilution a year ago. The market was looking scary for a brief while. Everyone and their mother, sister, and brother have been waiting for "the correction"....there are countless bodies of short sellers with arrows in their backs who have tried to time "the" correction...they continue to try and fight the fed and slower global markets that need to continue to pour money here for better returns...the spreads between our bonds and theirs continues to cause imbalances never seen before...I suspect like most it will not end well but at same time doesn't necessarily mean you have to give away the store...that's what 43 million and counting are hoping for...case in point the post your referencing |
|
|
|
Post by joeypotsandpans on Feb 8, 2020 16:00:41 GMT -5
Charlie what basal are you taking? I very rarely if ever go below 80. I haven't had to take a spirometry test since my first one a couple of years ago. My endo is phenomenal, I am so lucky to have him...he's been a prescriber and huge advocate from day 1
|
|
|
|
Post by joeypotsandpans on Jan 30, 2020 9:40:26 GMT -5
Back from my annual recharge vaca in Phuket, see below showing continued rising lows on relative strength on weekly chart. The test of the 1.50 area has been on weak volume compared to the breakout from previous range. Still very constructive IMO showing accumulation.  |
|
|
|
Post by joeypotsandpans on Jan 10, 2020 11:23:26 GMT -5
Volume coming into MNKD shares today. now. summary volume is over 1 million now 1,101,726 shares traded at 52 mins of trade. finance.yahoo.com/quote/MNKD?p=MNKDadded, 1,212,075 shares at 1 hour of trade. through $1.50 $1.57 is the next hard resistance, if price hits that it will test 1.50 again. break and hold of these wedge targets eventually targets $2.35 on the wedge, @ the same the triangle break. all I've got. let's see. hey, joeypotsandpans and all. more eyeballs the better. what do you have? Peppy, been traveling, back in Phuket today, will look at it in the morning, right now it's 11:20p Friday night here, have a a couple of Makers Mark's some Afrezza and saw the s/p so was just checking on scripts 😉 |
|
|
|
Post by joeypotsandpans on Dec 29, 2019 19:05:53 GMT -5
My response that has been filtered and not yet posted: In your previous article you had insinuated that the rate was moved up 2% based on not meeting the covenant. I questioned you whether you were assuming or you knew. You then replied as it was essentially a foregone conclusion based on missing the covenant with MidCap. Well just like your mentor you made statements or conjecture that didn't happen because there was an amendment agreed upon. I say like your mentor because for years he would make reference to the dire cash situation, and then poof! The unforeseen arrival of UTHR and the NON-DILUTIVE cash that came with it along with the potential income stream. Now you're stating in a factual manner that the shares will be pinned under $1.60 until June because less than half the original warrants may remain outstanding. John do you own 1 or 10 shares of MNKD to make the "I am long disclosure" after all you would be "honest" in your disclosure if you were long 1,10, or 100 shares for that matter. Or are you technically neutral because you have sold covered calls in anticipation of the $1.60 ceiling/cap? As a savvy investor, why would one remain long and continue to write/raise negative FUD based articles? Wouldn't the opportunity loss cost more tying up those funds on an ongoing basis as opposed to finding far greener pastures? Something just doesn't pass the smell test here IMO I find this amusing, so either Kastanes read your post or one of the puppets/messenger pigeons alerted him to it....his response was that proboard members were welcome to respond to his articles ....yet my comments/questions were conveniently omitted just like his mentor's articles....they don't get omitted on any other articles I have responded to on SA. The cop out is generally that they don't control the SA moderators lol....also I had posted something on another thread here about some have not learned to stop feeding the trolls, evidently that was pulled for whatever reason? Conflict of interest perhaps? I'm curious as to which moderator here pulled that post? John Kastanes Comments3575 | + Follow Author’s reply » From sportsrancho on proboards: That is so true Peppy! he could use his voice for good but he doesn’t ..that’s because he’s been calling for BK for years.( Unlike Spencer). I blocked him years ago, after many private conversations I called him a short, that is something I rarely do. To this day I don’t believe he shorts stocks but I wanted to let him know that I felt like he sounded like one. It’s my opinion that he’s obsessive about thinking Mannkind is going under. --------------------- sportsrancho - you and others on proboards are welcome to post comments on my articles.
Evidently not as my comment which was not derogatory in the least was "selectively edited". 29 Dec 2019, 10:17 AMReply2 |
|
|
|
Post by joeypotsandpans on Dec 27, 2019 14:45:23 GMT -5
My response that has been filtered and not yet posted: In your previous article you had insinuated that the rate was moved up 2% based on not meeting the covenant. I questioned you whether you were assuming or you knew. You then replied as it was essentially a foregone conclusion based on missing the covenant with MidCap. Well just like your mentor you made statements or conjecture that didn't happen because there was an amendment agreed upon. I say like your mentor because for years he would make reference to the dire cash situation, and then poof! The unforeseen arrival of UTHR and the NON-DILUTIVE cash that came with it along with the potential income stream. Now you're stating in a factual manner that the shares will be pinned under $1.60 until June because less than half the original warrants may remain outstanding. John do you own 1 or 10 shares of MNKD to make the "I am long disclosure" after all you would be "honest" in your disclosure if you were long 1,10, or 100 shares for that matter. Or are you technically neutral because you have sold covered calls in anticipation of the $1.60 ceiling/cap? As a savvy investor, why would one remain long and continue to write/raise negative FUD based articles? Wouldn't the opportunity loss cost more tying up those funds on an ongoing basis as opposed to finding far greener pastures? Something just doesn't pass the smell test here IMO |
|
|
|
Post by joeypotsandpans on Dec 27, 2019 13:53:45 GMT -5
Lol, the street knows what the issue is and it doesn't have anything to do with "our man", guess you didn't get the memo: For those that didn't get the memo: Read more: mnkd.proboards.com/thread/11542/hfm-news?page=19#ixzz69KBtpgGACan anyone, anyone at all answer the question? What could anyone possibly do better than the current board in getting Tier 2 coverage for all the major insurers that still continue to deny the folks that want Afrezza or cancel them after their open enrollment when they have limited choices from their employer. When someone can step forward and honestly figure out a viable solution to the biggest issue facing this company's flagship product then I'm all ears. What's your solution genius? Keep replacing CEO's with people that don't have a clue or experience on how to deal with the health insurance oligopoly? Fortunately for me I rec'd my last refill this week from Express Scripts, now that they have been taken out by CIGNA there is one less player in the field...no, no anti-trust issues here (rolls eyeballs) lol, moving along... I am pleased you got your refill. Unfortunately you can’t see the complete picture of Castagnas lack of performance as CEO of MNKD. You are blinded with loyalty because he helped you personally to get your initial prescription filled. He spent time helping one individual get a prescription (which I don’t trivialize). As CEO he should be spending his time seeing that the masses have access to Afrezza. That is his job! For which he is well compensated for. The experience his proponents continually point to is laughable. Never a CEO and very questionable work history. When you run a company there are constantly challenges that may seem insurmountable to the masses but they need to be overcome. Finding the solution is what separates a good CEO from mediocre. What part of my question do you not understand, maybe I can help? Mike didn't help me personally by spending countless hours of getting on the phone and calling my insurance company, he sent an email to the area rep to get involved, that took him all of less than a minute...his experience as a PharmD and his time at Amgen far outweighs the proposed nominees IMO with regard to dealing with the intricacies of insurance infrastructure and bureaucracy. Do you even know what the educational background is and what it takes to get a PharmD? After completing a rigorous 3-4yrs (depending on the program) there are two components to the extensive exam, the drug knowledge portion and the law knowledge portion, thus two parts to the exam that has to be taken separately and successfully completed. The latter two years prior to the exam are spent in rotation and clinical. Include his MBA from Wharton, and on hand experience with reworking products at his past employers and I'm not quite sure where your term "very questionable work history" derives from. I get that many are sour over their investment choice, but the ones in the know of how this company was going to be affected for a lengthy period of time (after the FDA approval and accompanying label) are the experienced ones that have taken advantage of the situation and profited from it. What's happened here is those that cannot live with the investment decisions they have made are deflecting that ownership of their decision everywhere else but at themselves. Individuals consistently gamble with options year after year for a XX bagger and continually have gotten played by the options specialists. Some folks need to pull their big boy/girl pants up and either move on or stop wasting their time day in and day out watching the pot boil...you either believe that the science and technology will eventually win out or look for other pastures...but to try and blame everything on a single individual is ludicrous IMO. |
|
|
|
Post by joeypotsandpans on Dec 27, 2019 12:18:52 GMT -5
When I refer to AUTOPILOT I mean that once Afrezza hits CRITICAL MASS it will snowball. As more users try Afrezza and realize it's benefits they will go on social media, attend support groups and it will snowball. Doctors will take notice and become ever more comfortable in it and will prescribe like GUMBALLS. It will take time which Mike has said. Mike has over 20 years experience and he knows what he is doing. Also Mike needs to keep the existing shareholders interested and will throw tidbits out from time to time. He also is out there getting new shareholders interested in the MNKD Story. I'm excited for the future. We have been through the ROUGH TIMES and SURVIVED. Up a few pennies and the ghost and clowns come out with their absolute false narratives about Castagna. We are at .28 pre split. The sooner Castagna gets replaced the sooner the share price returns to $10.00 where we should be right now. The street has no confidence in your man. Lol, the street knows what the issue is and it doesn't have anything to do with "our man", guess you didn't get the memo: For those that didn't get the memo: Read more: mnkd.proboards.com/thread/11542/hfm-news?page=19#ixzz69KBtpgGACan anyone, anyone at all answer the question? What could anyone possibly do better than the current board in getting Tier 2 coverage for all the major insurers that still continue to deny the folks that want Afrezza or cancel them after their open enrollment when they have limited choices from their employer. When someone can step forward and honestly figure out a viable solution to the biggest issue facing this company's flagship product then I'm all ears. What's your solution genius? Keep replacing CEO's with people that don't have a clue or experience on how to deal with the health insurance oligopoly? Fortunately for me I rec'd my last refill this week from Express Scripts, now that they have been taken out by CIGNA there is one less player in the field...no, no anti-trust issues here (rolls eyeballs) lol, moving along... |
|
|
|
Post by joeypotsandpans on Dec 27, 2019 11:13:49 GMT -5
I could only read the first three pages of this thread. This move by MC has been way over analyzed. This is just not a big deal. You would have thought it was the end in MannKind. Sorry to my buddies who think it’s horrible, I must disagree. What's this?......oh a voice of reason, how refreshing! May the coming year bring you excellent health, sprinkled with some very good times young man  |
|
|
|
Post by joeypotsandpans on Dec 24, 2019 16:13:40 GMT -5
Another cup and handle forming on the daily charts, top of cup is 1.48-1.50 resistance, if taken out a decent run should follow: [chart omitted to save space] the amendment to the debt facility extends the dilution waiting time for the wanting supply side...this is what Nate is referring to regarding "stuck". There were two ways out for the borrowed side, either getting whole via a BK or continued dilution, the credit facility took away more immediate ways to mitigate their deficit of shares...yes they can hedge the position but as I have mentioned in the past in the end it's a zero sum game and the only ones giving them relief are the ones that continually pay premium through the options to help that position offset the carrying cost and exposure. If you're gambling on going long options or have been for years there have been very limited times that has been a winning strategy (most notably the run up to $6-7 area previously) otherwise being long shares is the only way to ensure when the next binary event takes place you don't have to worry about timing via options Joey thanks as always for your perspective. Haven't we seen the "cup and handle" many times before, yet the resistance has never been taken out such that we could enjoy a sustained run? (Other than the pump-and-dump up to $6-7 you mentioned, but of course that didn't sustain anyway.) So I'm wondering what is the value in spotting the cup and handle pattern, when it's never turned into good news for us shareholders before. And as for the folks you mention on the borrowed side, aren't 80% or more of those people so far ahead on those trades that they could simply close out their positions and lock in their gains? It doesn't seem like they would need BK or dilution to do that, as they have already made a killing because they got into their positions when share price was way higher. Being aware of the possible patterns is one thing, the idea is to know where the sp is currently and where those resistance levels are to see if and when they get breached. A confirmation of breaching that resistance (generally with solid volume) in turn validates the pattern and should lend confidence to the bulls that a new uptrend is taking hold. Bottomline, the pattern itself isn't a guarantee, but if the top of the cup and handle gets taken out I'd be a lot more apt to trading and/or investing from the long side using that former resistance as a new support level. Regarding the the recent 8k and whether or not it showed weakness as most have mentioned, it looks like Mr. Market took it in relative stride for the moment and basically just yawned...I look at what was perceived by many as "negative news" and a somewhat muted reaction in s/p as more bullish, at least for now anyway. The frustrations, IMO, are more from the naked option's gamblers who apparently haven't learned that options are better served for hedging or adding to income via selling premiums on an ongoing basis, again IMO. Be safe & Happy Holidays |
|
